MapLight Therapeutics officer proposes $49.4K sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MapLight Therapeutics, Inc. (MPLT) reported a proposed sale by its officer Kristopher Hanson of 1,827 common shares, with an aggregate market value of $49,365.54 and an approximate sale date of April 15, 2026. The notice states the shares are to be sold solely to satisfy tax-withholding obligations in connection with restricted stock unit vesting.
Key Figures
Key Terms
Restricted Stock Unit Grant financial
tax-withholding obligations financial
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.